Summary
In two separate cohorts of breast cancer patients presenting without evidence of distant metastatic disease, high levels of tumour cyclic AMP binding proteins (> 8 pmol/mg cytosol protein) have been shown to be associated with poor prognosis in terms of both disease recurrence and overall survival. This association is independent of known established prognostic factors and allows the identification of a small subgroup of patients whose outlook warrants the implementation of aggressive systemic therapy.
This is a preview of subscription content, log in via an institution to check access.
References
Bodwin JS, Cho Chung YS: Inverse relations between estrogen receptors and cyclic adenosine 3'5' monophosphatebinding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3'5'-monophosphate treatment on ovariectomy. Cancer Res 38: 3410–3413, 1978
Cho-Chung YS, Clair T, Schwimmer M, Steinberg L, Rego J, Grantham F: Cyclic adenosine 3'5'-monophosphate receptor proteins in hormone-dependent and -independent rat mammary tumors. Cancer Res 41: 1840–1844, 1981
Miller WR, Elton RA, Dixon JM, Chetty U, Watson DMA: Cyclic AMP binding proteins and prognosis in breast cancer. Br J Cancer 61: 263–266, 1990
Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359–377, 1957
Hawkins RA, Hill A, Freedman D: A simple method for the determination of oestrogen receptor concentrations in breast tumors and other tissues. Clin Chim Acta 64: 203–210, 1975
Miller WR, Telford J, Dixon JM, Hawkins RA: Androgen receptor activity in human breast cancer and its relationship with oestrogen and progestogen receptor activity. Eur J Cancer Clin Oncol 21: 539–542, 1985
Miller WR, Senbanjo RO, Telford J, Watson DMA: Cyclic AMP binding proteins in human breast cancer. Br J Cancer 52: 531–535, 1985
Scatchard G: The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51: 660–672, 1949
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254
Cho-Chung YS: Role of cyclic AMP receptor proteins in growth, differentiation and suppression of malignancy: new approaches to therapy. Cancer Res 50: 7093–7100, 1990
Miller WR, Hulme MJ, Cho-Chung YS, Elton RA: Types of cyclic AMP binding proteins in human breast cancers. Eur J Cancer Clin Oncol. In Press
Cho-Chung YS, Clair T, Tortora G, Yokozaki H: Role of site-selective cAMP analogs in the control and reversal of malignancy. Pharmac Ther 50: 1–33, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miller, W.R., Watson, D.M.A., Jack, W. et al. Tumour cyclic AMP binding proteins: an independent prognostic factor for disease recurrence and survival in breast cancer. Breast Cancer Res Tr 26, 89–94 (1993). https://doi.org/10.1007/BF00682703
Issue Date:
DOI: https://doi.org/10.1007/BF00682703